In brief

BMJ 2005; 330 doi: (Published 14 April 2005) Cite this as: BMJ 2005;330:862

Cheap, fixed dose treatment is planned for malaria: The Drugs for Neglected Diseases Initiative (a non-profit drug development organisation) and Sanofi-Aventis have agreed to develop a new, fixed dose combination of artemisinin based compound to treat falciparum malaria in Africa. The target price of the treatment is less than $1 (£0.53; €0.77) for a three day course.

US …

View Full Text

Sign in

Log in through your institution